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Abstract
Reproductive disorders that are common/increasing in prevalence in human males may arise because of deficient androgen
production/action during a fetal ‘masculinization programming window’. We identify a potentially important role for
Chicken Ovalbumin Upstream Promoter-Transcription Factor II (COUP-TFII) in Leydig cell (LC) steroidogenesis that may
partly explain this. In rats, fetal LC size and intratesticular testosterone (ITT) increased ,3-fold between e15.5-e21.5 which
associated with a progressive decrease in the percentage of LC expressing COUP-TFII. Exposure of fetuses to dibutyl
phthalate (DBP), which induces masculinization disorders, dose-dependently prevented the age-related decrease in LC
COUP-TFII expression and the normal increases in LC size and ITT. We show that nuclear COUP-TFII expression in fetal rat LC
relates inversely to LC expression of steroidogenic factor-1 (SF-1)-dependent genes (StAR, Cyp11a1, Cyp17a1) with
overlapping binding sites for SF-1 and COUP-TFII in their promoter regions, but does not affect an SF-1 dependent LC gene
(3b-HSD) without overlapping sites. We also show that once COUP-TFII expression in LC has switched off, it is re-induced by
DBP exposure, coincident with suppression of ITT. Furthermore, other treatments that reduce fetal ITT in rats
(dexamethasone, diethylstilbestrol (DES)) also maintain/induce LC nuclear expression of COUP-TFII. In contrast to rats, in
mice DBP neither causes persistence of fetal LC COUP-TFII nor reduces ITT, whereas DES-exposure of mice maintains COUP-
TFII expression in fetal LC and decreases ITT, as in rats. These findings suggest that lifting of repression by COUP-TFII may be
an important mechanism that promotes increased testosterone production by fetal LC to drive masculinization. As we also
show an age-related decline in expression of COUP-TFII in human fetal LC, this mechanism may also be functional in
humans, and its susceptibility to disruption by environmental chemicals, stress and pregnancy hormones could explain the
origin of some human male reproductive disorders.
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Introduction
Phenotypic masculinization is a pivotal event in mammalian
development, diverting the fetus from the female ‘set-up’
programme of development. The key driver of this process is
testosterone produced by the fetal Leydig cells (LC) [1]. This
occurs early in fetal development, immediately after testis
differentiation, in what has been termed the masculinization
programming window (MPW; e15.5–e18.5 in the rat) [1,2]. The
level of androgen production/action in the MPW critically
determines later reproductive development and final size of all
male reproductive organs in the rat [2,3,4,5], although androgen
production after the MPW is important for reproductive organ
differentiation and growth [1,4,5]. Deficiency in androgen pro-
duction/action within the MPW results in ‘testicular dysgenesis
syndrome (TDS)’ disorders such as hypospadias, cryptorchidism
and reduced testis size/sperm production in rats [1,3,4,5] and
humans [6,7,8].
Therefore, regulation of testosterone production by fetal LC
within and after the MPW is fundamentally important for normal
male development, yet the mechanisms involved are largely
unknown (Fig. 1A). In rodents, it has been presupposed that
unknown paracrine mechanisms stimulate LC steroidogenesis
during this period, as secretion of the main physiological LC
stimulator, luteinizing hormone (LH), does not begin until after the
MPW, and knockout of either LHb or its receptor does not impair
masculinization [1]. In contrast, in humans/primates, inactivating
mutations of the LH receptor, although not of LH, impair
masculinization [1]. This is because the primate placenta produces
an LH-like chorionic gonadotropin (CG) that stimulates fetal LC,
whereas the rodent placenta does not [1]. However, even in
humans, the balance of evidence points to CG not being the sole
driver of fetal LC steroidogenesis during the presumptive MPW, so
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Consequently, ignorance about the regulation of fetal testis
steroidogenesis in and around the MPW is a major obstacle to
identifying how normal masculinization is driven and what can
impact this to induce TDS/masculinization disorders.
We have developed an animal model for TDS involving fetal
exposure to the ubiquitous environmental chemical, dibutyl
phthalate (DBP) [9]. Exposure of pregnant rats to DBP suppresses
fetal LC steroidogenesis before and after the MPW because of the
down-regulation of several genes that play critical roles in LC
steroidogenesis, all of which are regulated by steroidogenic factor 1
(SF-1) [10,11,12,13,14,15]. However, SF-1 expression itself is
unaffected by DBP exposure and not all SF-1-dependent genes
expressed in the fetal testis are impacted [12]. Whilst searching for
an explanation for the latter observations, we identified an
important role for chicken ovalbumin upstream promoter
transcription factor II (COUP-TFII; also known as NR2F2).
COUP-TFII is a widely expressed orphan nuclear receptor of the
steroid/thyroid family [16]. Moreover, prepubertal deletion of
COUP-TFII in the mouse results in failure of adult LC to
differentiate, leading to near absence of testosterone production
and infertility [17], implying a key role in (adult) LC development.
The initial aim of the present studies was to evaluate if
a mechanism involving COUP-TFII expression in fetal LC could
explain the steroidogenic effects of DBP exposure in the rat, which
our findings suggest it does. However, in so doing, wider
implications emerged, namely evidence that regulation of LC
steroidogenesis in and after the MPW may not be under
stimulatory control by paracrine mechanisms, but rather may be
actively repressed (by COUP-TFII) and that lifting of this
repression is crucial for expansion of LC steroidogenic function
during and after the MPW. We show that various treatments that
impair fetal LC steroidogenesis in rats all maintain or induce
COUP-TFII expression in fetal LC, and that prevalence of
COUP-TFII expression in fetal LC in rats and mice is inversely
related to ITT in every situation investigated. Vulnerability of this
local mechanism to disruption by endogenous and exogenous
factors could potentially explain why disorders (TDS) stemming
from mild deficiency in androgen action in the MPW are common
in humans.
Results
DBP exposure of fetal rats and the induction of later TDS
disorders
To characterize the relationship between COUP-TFII and
steroidogenesis, we initially utilized an established DBP treatment
regime (500 mg/kg/day from e13.5–e21.5) that induces a major
Figure 1. Critical importance of local (unknown) factors in the regulation of testosterone production by fetal Leydig cells in the rat
during the masculinization programming window (A) and downstream effects of impairment of testosterone production by fetal
exposure to dibutyl phthalate (DBP; 500 mg/kg/day from e13.5–e21.5) (B).
doi:10.1371/journal.pone.0037064.g001
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leading to a high incidence of TDS-like disorders in adulthood
(Fig. 1B).
DBP effects on intratesticular testosterone, LC number
and nuclear/cytoplasmic volume
In control animals, intratesticular testosterone (ITT), corrected
for the number of LC per testis (see below), significantly and
progressively increased between e15.5 and e19.5/e21.5. No such
increase occurred in testes of DBP-exposed animals (Fig. 2A). We
performed stereological quantification of LC number (Fig. 2B) and
cytoplasmic volume per LC (Fig. 2D), which both increased ,3-
fold between e15.5 and e21.5 in control animals with a smaller
increase in LC nuclear volume (Fig. 2C). DBP exposure had no
effect on the number of fetal LC at any age (Fig. 2B), but
prevented the normal age-dependent increase in LC cytoplasmic
volume (Fig. 2D) and nuclear volume (Fig. 2C). The increase in
LC cytoplasmic volume in controls between e15.5 and e21.5 and
its prevention by DBP exposure (Fig. 2D) paralleled the observed
changes in ITT (Fig. 2A).
DBP-exposure down-regulates mRNA expression of
selected SF-1-regulated steroidogenic genes
Previous studies have demonstrated the suppression of steroido-
genic enzyme gene expression, such as StAR, Cyp11a1 and
Cyp17a1, in the fetal rat testis after exposure to DBP
[10,11,12,13,14,15]. We therefore used quantitative real-time
PCR to evaluate steroidogenic enzyme gene expression in e21.5
control and DBP-exposed animals, when ITT suppression is
maximal (Fig. 2A). Exposure to DBP reduced the mRNA
expression of Cyp11a1, StAR and Cyp17a1 (Figs. 3A–C), whereas
mRNA expression for 3b-HSD was unaffected (Fig. 3D). We have
previously published that these genes are all SF-1-regulated [12]
and analysis of their promoter regions revealed that the DBP-
affected genes (Cyp11a1, StAR and Cyp17a1) all have overlapping
SF-1/COUP-TFII binding sites in their promoters, whereas 3b-
HSD only has an SF-1 binding site (Table 1). Another gene with
SF-1 and COUP-TFII binding sites, but expressed in Sertoli cells
is Amh (Table 1). Exposure to DBP did not affect Amh mRNA
expression (Fig. 3I). These gene expression studies utilized whole
testes, but the genes analyzed are cell-specific in the fetal testis, as
confirmed by immunoexpression studies comparing Cyp11a1
(Figs. 3E,F), 3b-HSD (Figs. 3G,H) and Amh (Figs. 3J,K), which
also confirmed selective suppression by DBP of Cyp11a1 but not
the latter two.
Figure 2. Effect of in utero exposure of rats to vehicle (control) or dibutyl phthalate (DBP: 500 mg/kg/day) on age-dependent
changes in intratesticular testosterone levels per 10
6 fetal fetal Leydig cells (A), Leydig cell number per testis (B), Leydig cell
nuclear volume (C) and Leydig cell cytoplasmic volume (D). Values in A are Means 6 SEM for 5–12 animals at each age (minimum of 3 litters
per group). Values in B–D are Means 6 SEM for 4–8 animals in each group (minimum of 3 litters per group). *p,0.05, **p,0.01, ***p,0.001, in
comparison with respective controls; other comparisons are indicated by capped lines.
doi:10.1371/journal.pone.0037064.g002
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and ITT in fetal LC
Since the LC-expressed genes down-regulated after DBP-
exposure all have overlapping SF-1/COUP-TFII binding sites in
their promoters, we studied the expression of COUP-TFII in testes
of control and DBP-exposed animals. Pregnant female rats were
treated with different doses of DBP (20, 100 and 500 mg/kg/day)
and the testes were examined at e21.5 (Fig. 4). Real-time PCR
analysis of COUP-TFII mRNA expression in whole fetal testes
showed no change between control and DBP-exposed animals
(Fig. S1), presumably because COUP-TFII is abundantly
expressed in several cell types in the fetal testis other than the
fetal LC (see below). We therefore utilized confocal microscopy
and high resolution tiled images of complete testis cross-sections to
investigate LC-specific COUP-TFII expression at e21.5 (Fig. 4A),
which we quantified stereologically (Fig. 4B,C). Most fetal LC in
fetuses exposed to 20 mg/kg/day DBP (DBP-20) were COUP-
TFII immunonegative at e21.5, as in controls, whereas in fetuses
exposed to 100 or 500 mg/kg/day (DBP-100 and DBP-500,
respectively) COUP-TFII was expressed in ,70% and ,85% of
fetal LC nuclei respectively (Fig. 4B,C). This dose-dependent effect
of DBP on the percentage of fetal LC expressing nuclear COUP-
TFII was inversely related to suppression of ITT (Fig. 4D). Some
non-Leydig interstitial cells appeared to express COUP-TFII in
their cytoplasm rather than the nucleus (Fig. 4B). However, this is
a processing artifact that results in aberrant nuclear morphology
Figure 3. Effect of in utero exposure of rats to vehicle (control) or dibutyl phthalate (DBP: 500 mg/kg/day) on steroidogenic enzyme
and anti-Mu ¨llerian hormone gene expression in testes at e21.5. (A) cytochrome P450, family 11, subfamily a, polypeptide 1 (Cyp11a1), (B)
Steroidogenic acute regulatory protein (StAR), (C) cytochrome P450, family 17, subfamily a, polypeptide 1 (Cyp17a1), (D) hydroxy-delta-5-steroid
dehydrogenase, 3 beta- and steroid delta-isomerase 1 (3b-HSD), (I) Anti-Mu ¨llerian hormone (Amh). Values are Means 6 SEM for 19–22 animals per
group (minimum of 5 litters per group). *p,0.05, **p,0.01, in comparison with respective control. (E–F) Immunohistochemistry for Cyp11a1 on e21.5
testis sections isolated from control (E) and DBP-500-exposed (F) animals. (G–H) Immunohistochemistry for 3b-HSD on e21.5 testis sections isolated
from control (G) and DBP-500-exposed (H) animals. (J–K) Immunohistochemistry for Amh on e21.5 testis sections isolated from control (J) and DBP-
500-exposed (K) animals. Scale bars E–H=20 mm.
doi:10.1371/journal.pone.0037064.g003
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nucleus), as illustrated by comparing COUP-TFII expression with
that of the nuclear-specific counterstain (DAPI; Fig. S2), confirm-
ing that COUP-TFII expression is confined to the nucleus in all
cells in which it is expressed in the fetal testis.
Age-dependent switching off of COUP-TFII nuclear
immunoexpression in fetal LCis prevented by DBP-
exposure
We then examined COUP-TFII expression in fetal LC during
normal development and how this was affected by exposure to
500 mg/kg/day DBP. At e15.5, testes from both control and
DBP-exposed fetuses expressed nuclear COUP-TFII in .85% of
fetal LC (3b-HSD immunopositive cells) (Fig. 5A,C). From e17.5
onwards in controls, the percentage of LC expressing nuclear
COUP-TFII progressively declined, such that by e21.5,10% of
LC were COUP-TFII-immunopositive. This correlated inversely
to the significant and progressive increase in ITT between e15.5
and e19.5/e21.5 in control animals (Fig. 2A). In contrast, in DBP-
exposed animals, COUP-TFII expression in fetal LC persisted
unchanged from e15.5 to e21.5 (Fig. 5A,C), which correlated with
prevention of the normal ITT increase after DBP-exposure
(Fig. 2A). COUP-TFII expression in interstitial cells other than
fetal LC did not change detectably with fetal age or DBP
treatment.
Late gestational exposure to DBP re-induces COUP-TFII
nuclear expression in fetal LC and reduces ITT
Several studies in the literature have shown that transfection of
COUP-TFII into steroidogeneic cells results in antagonism of SF-1
action [18,19,20,21,22,23], consistent with our observations. We
therefore sought to obtain direct evidence for this in fetal rat LC
by using a Lentivirus encoding COUP-TFII (Lv-COUP-TFII) to
over-express COUP-TFII in isolated fetal testicular cells at e17.5
and thereby cause a reduction in StAR, Cyp11a1 and Cyp17a1
mRNA expression and testosterone production. Unfortunately,
this ex vivo approach resulted in cell death after infection with LV-
COUP-TFII (data not shown). There are also inherent problems
with applying similar approaches to the ex vivo culture of fetal LC,
which rapidly (,48 h) lose their steroidogenic function after
isolation [24]. Therefore, to provide more definitive evidence that
nuclear COUP-TFII expression in fetal LC was associated causally
with reduced ITT, DBP treatment was delayed until a time-point
(e19.5–e20.5; =late treatment window) when ,80% of LC have
normally switched off nuclear expression of COUP-TFII (Fig. 5).
This ‘late window’ exposure to DBP-500 re-induced COUP-TFII
expression in ,70% of the fetal LC at e21.5 (Fig. 6D,E), while
control (corn oil-exposed) animals only expressed COUP-TFII in
a minority of fetal LC (Fig. 6B,E). Late window exposure to DBP-
500 also resulted in a .50% reduction in ITT compared with
controls (Fig. 6F).
The above results are consistent with cause and effect between
DBP-induction or prolongation of COUP-TFII expression in fetal
LC and suppression of ITT. We therefore investigated whether
other treatments which have been shown to reduce fetal
testosterone production in rats might target the same mechanism.
Effects of exposure to DBP 6 Dex on fetal LC nuclear
expression of COUP-TFII and ITT
We have previously shown that in utero exposure to the synthetic
glucocorticoid dexamethasone (Dex) amplifies the suppressive
effects of DBP on fetal testis ITT and may thus induce more severe
TDS disorders [3]. Dex exposure alone (e13.5–e20.5) increased
the percentage of fetal LC expressing COUP-TFII at e21.5 to
50% compared with ,8% in vehicle-exposed controls (Fig. 7A,B).
In comparison, exposure to DBP-500 increased the proportion of
COUP-TFII-positive LC to ,85%, and co-exposure to both
DBP-500 + Dex caused a similar magnitude of change (Fig. 7A,B).
The DBP 6 Dex-induced changes in COUP-TFII expression in
LC again showed a striking inverse relationship to ITT (Fig. 7C)
(r
2=0.89, p,0.0001, linear regression analysis between left testis
ITT and right testis percentage of COUP-TFII positive fetal LC).
Exposure to DBP 6 Dex reduced the mRNA expression of
Cyp11a1, StAR and Cyp17a1 (Fig. S3A–C), with the degree of
suppression paralleling the percentage of fetal LC that expressed
COUP-TFII in their nuclei (Fig. 7B). In contrast to the effects on
Cyp11a1, StAR and Cyp17a1, DBP 6 Dex exposure had no effect
on the expression of another LC-specific gene 3b-HSD (Fig. S3D).
To further explore a possible link between COUP-TFII expression
and suppression of SF-1-dependent genes, we investigated whether
DBP 6 Dex exposure had any effect on the expression of the SF-1
target gene Amh in Sertoli cells, as COUP-TFII is absent from
Sertoli cells at all ages and treatments studied (Figs. 4,5,6,7). As
Table 1. An overview of SF-1, COUP-TFII and SF-1/COUP-TFII binding sites in the promoters of StAR, Cyp11a1, Cyp17a1, Hsd3b1 and
Amh.
Promoter binding sites (bp downstream of transcription start site)
Gene name NCBI accession number SF-1 binding site COUP-TFII binding site SF-1/COUP-TFII binding site
StAR NM_031558 2150 290*
2110
2460
2640
2760
21330
Cyp11a1 NM_017286 - - 250
21840
Cyp17a1 NM_012753 257 2278* 23859
Hsd3b1 (3b-HSD) NM_008293 21530 - -
Amh NM_012902 22529 22325 -
*: ‘‘weak’’ COUP-TFII binding site.
StAR=steroidogenic acute regulatory protein; Cyp11a1=cytochrome P450, family 11, subfamily a, polypeptide 1; Cyp17a1=cytochrome P450, family 17, subfamily a,
polypeptide 1; Hsd3b1=hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1; Amh=anti-Mu ¨llerian hormone; SF-1=steroidogenic factor-1;
COUP-TFII=chicken ovalbumin upstream promoter transcription factor II; bp=basepair.
doi:10.1371/journal.pone.0037064.t001
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unaffected by DBP 6 Dex exposure. LHR-mediated drive to LC
steroidogenesis may become progressively important in late
gestation (beyond e18.5) in rats [1], but none of the treatments
significantly altered LHR gene expression at e21.5 (Fig. S4A); we
were unable to measure fetal LH levels due to lack of sufficient
blood.
Effects of fetal exposure of rats to DES on expression of
COUP-TFII, ITT and SF-1 target gene expression
Previous research has shown that in utero exposure of rats to
diethylstilbestrol (DES) results in reduced ITT [25]. Therefore, we
investigated whether the DES-induced decrease in ITT was
related to altered immunoexpression of COUP-TFII in the fetal
LC at e21.5. In utero exposure to DES resulted in an increase in the
percentage of COUP-TFII-positive LC when compared to
controls (Figs. 8A–C), which again correlated inversely with ITT
levels (Fig. 8D). Testes from DES-exposed males had significantly
Figure 4. Altered COUP-TFII expression in fetal rat Leydig cells after in utero exposure to vehicle (control) or to different doses of
dibutyl phthalate (DBP) and the relationship to intratesticular testosterone levels at e21.5. (A–B) Triple immunofluorescence for SMA
(blue), 3b-HSD (red) and COUP-TFII (green) on testis sections from representative vehicle (control) and DBP-exposed animals. Note that major
persistence of COUP-TFII expression in fetal Leydig cells is observed after exposure to DBP-100 and DBP-500 (100 and 500 mg/kg/day, respectively),
whereas DBP-20 (20 mg/kg/day) had a much smaller effect. Asterisks indicate Leydig cell aggregates that are predominantly immunopositive for
COUP-TFII. SC=seminiferous cords. Scale bar A=200 mm, B=20 mm. (C) Quantification of the percentage of COUP-TFII positive fetal Leydig cells in
vehicle (control) and DBP-exposed animals using tiled high resolution images as shown in panel A. Values are Means 6 SEM for 6–9 animals per
treatment group (minimum of 3 litters per group). **p,0.01, ***p,0.001, in comparison with respective control; other comparisons are indicated by
capped lines. (D) Corresponding intratesticular testosterone levels for the treatment groups in panels A and B. Values are Means 6 SEM for 4–21
animals per group (minimum of 3 litters per group). **p,0.01, ***p,0.001, in comparison with respective control.
doi:10.1371/journal.pone.0037064.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37064Figure 5. Age-dependent alteration in COUP-TFII expression in fetal rat Leydig cells in vehicle-exposed control rats and after in
utero exposure to dibutyl phthalate (DBP; 500 mg/kg/day). (A–B) Triple immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-TFII
(green) on fetal testis sections from vehicle (control) and DBP-exposed animals. Arrows in A indicate examples of individual Leydig cells positive for
COUP-TFII whereas asterisks indicate DBP-induced aggregates of Leydig cells which are predominantly COUP-TFII-immunopositive. SC=seminiferous
cords. Scale bar A=20 mm, B=200 mm. (C) Quantification of the percentage of COUP-TFII positive fetal Leydig cells in vehicle (control) and DBP-
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PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37064exposed animals using tiled high resolution images as shown in panel B. Values are means 6 SEM for 5–8 animals at each age (minimum of 3 litters
per group). ***p,0.001, in comparison with respective control; other comparisons are indicated by capped lines.
doi:10.1371/journal.pone.0037064.g005
Figure 6. Altered COUP-TFII expression in fetal rat Leydig cells after in utero exposure to vehicle (control) or to 500 mg/kg/day
dibutyl phthalate (DBP) from e19.5-e20.5 (late treatment window) and the relationship to intratesticular testosterone levels at
e21.5. (A–D) Triple immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-TFII (green) on testis sections from representative vehicle (control)
and DBP-exposed animals on high resolution tiled images (A and C) and at higher power (B and D). Asterisks in panel D indicate Leydig cell
aggregates that are predominantly immunopositive for COUP-TFII. SC=seminiferous cords. Scale bars in A and C=200 mm, in B and D=20 mm. (E)
Quantification of the percentage of COUP-TFII positive fetal Leydig cells in animals from the treatment groups shown in panels A–D. Values are Means
6 SEM for 8–10 animals per treatment group (minimum of 3 litters per group). ***p,0.001, in comparison with respective control. (F) Corresponding
intratesticular testosterone levels for the treatment groups in panels A–D. Values are Means 6 SEM for 18–20 animals per group (minimum of 3 litters
per group). ***p,0.001, in comparison with respective control.
doi:10.1371/journal.pone.0037064.g006
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(Fig. 8E), StAR (Fig. 8F) and Cyp17a1 (Fig. 8G), whereas the SF-1
target gene in Sertoli cells, Amh, was unaffected by DES treatment
(Fig. 8H). The more pronounced suppression of both ITT and LC
gene expression found after DES treatment, when compared with
that found after DBP treatment (Fig. 2,3), is probably explained by
the pronounced suppression of LHR expression found at e21.5 in
DES-exposed animals (thus limiting LH-stimulation of the LC),
a change not found after DBP exposure (Fig. S4).
DBP exposure of mice does not alter COUP-TFII nuclear
expression in fetal LC and has no effect on ITT, whereas
exposure to DES does
In contrast to rats, gestational exposure of mice to DBP has no
effect on ITT (Fig. 9D) or on LC steroidogenic enzyme expression
[26,27], a species difference that is unexplained. We investigated if
a species-specific difference in the effect of DBP on nuclear
expression of COUP-TFII in fetal LC might explain this. At e18.5
in mice (equivalent to e21.5 in rats) gestational exposure to DBP-
500 (treatment since e11.5) did not alter the percentage of fetal LC
nuclei that were immunopositive for COUP-TFII; the percentage
remained low as in vehicle-exposed controls (Fig. 9A–C), in
contrast to the results in DBP-exposed rats (Figs. 4B,5C).
However, as previously reported [28], we found that exposure of
pregnant mice to diethylstilbestrol (DES) resulted in a reduction in
ITT in male fetuses. In mice, as in rats (Fig. 8), DES-exposure
resulted in 40% of the fetal LC being positive for COUP-TFII
compared to 12% in controls (Fig. 9E–G). This correlated
inversely with ITT after DES-exposure which was reduced by 7-
fold in DES-exposed animals when compared with controls
(Fig. 9H).
COUP-TFII expression in human fetal LC is down-
regulated during development
To evaluate whether these findings in rodents are relevant in
humans, we quantified fetal LC expression of nuclear COUP-TFII
in testes from late 1
st trimester, early 2
nd trimester and late 2
nd
trimester samples. This showed that the percentage of LC nuclei
that were immunopositive for COUP-TFII declined over this
developmental time period (Fig. 10), a trend similar to, although
Figure 7. Altered COUP-TFII expression in fetal rat Leydig cells after in utero exposure to vehicle (control), to dexamethasone (Dex;
100 mg/kg/day) to dibutyl phthalate (DBP; 500 mg/kg/day) or combined DBP + Dex and the relationship to intratesticular
testosterone levels at e21.5. (A) Triple immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-TFII (green) on testis sections from
representative vehicle (control) and DBP6Dex-exposed animals on higher power images. Note that exposure to Dex alone resulted in increased
occurrence of COUP-TFII-immunopositive fetal Leydig cells (arrows) compared with controls and that combined exposure to DBP-500 + Dex or
exposure to DBP-500 alone resulted in most Leydig cells being immunopositive for COUP-TFII (asterisks). SC=seminiferous cords. Scale bar=20 mm.
(B) Quantification of the percentage of COUP-TFII positive fetal Leydig cells in animals from the treatment groups shown in panel A. Values are Means
6 SEM for 3–6 animals per treatment group (minimum of 3 litters per group). ***p,0.001, in comparison with respective control; other comparisons
are indicated by capped lines. (C) Corresponding intratesticular testosterone levels for the treatment groups in panel A. Values are Means 6 SEM for
19–22 animals per group (minimum of 3 litters per group). **p,0.01, ***p,0.001, in comparison with respective control; other comparisons are
indicated by capped lines.
doi:10.1371/journal.pone.0037064.g007
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e15.5–e21.5 (Fig. 5). Very early 1
st trimester samples, equivalent to
e15.5 in the rat, were unavailable for study.
Fetal LC from complete androgen receptor knockout
(ARKO) mice are predominantly immunonegative for
COUP-TFII expression
Since reduced ITT was found in every instance when there was
abnormal maintenance/induction of COUP-TFII expression in
fetal rodent LC, we considered whether the former could be
driving the latter. This reverse causation seems unlikely, since in
complete androgen receptor knockout (ARKO) mice the fetal LC
Figure 8. Effect of in utero exposure of rats to vehicle (control) or to diethylstilbestrol (DES 100 mg/kg on e13.5, e15.5, e17.5, e19.5
and e20.5) on COUP-TFII immunoexpression in fetal Leydig cells at e21.5. (A) Triple immunofluorescence for SMA (blue), 3b-HSD (red) and
COUP-TFII (green) on testis sections from representative vehicle (control) and DES-exposed animals. Note that in controls occasional fetal Leydig cells
are COUP-TFII-immunopositive (arrow) whereas exposure to DES resulted in a 3-fold increase in the % of COUP-TFII-immunopositive Leydig cells
(asterisks). SC=seminiferous cords. Scale bar=20 mm. (B) Quantification of the percentage of COUP-TFII positive fetal Leydig cells in animals from the
treatment group shown in panel A. Values are Means 6 SEM for 3–13 animals per treatment group (minimum of 3 litters per group). ***p,0.001, in
comparison with respective control. (C) Corresponding intratesticular testosterone levels for the treatment groups in panel A. Values are Means 6
SEM for 13–25 animals per group (minimum of 3 litters per group). ***p,0.001, in comparison with respective control. (E) cytochrome P450, family
11, subfamily a, polypeptide 1 (Cyp11a1), (F) Steroidogenic acute regulatory protein (StAR), (G) cytochrome P450, family 17, subfamily a, polypeptide 1
(Cyp17a1), (H) Anti-Mu ¨llerian hormone (Amh) gene expression in testes from control and DES-exposed males at e21.5. Values are Means 6 SEM for
11–24 animals per group (minimum of 3 litters per group). ***p,0.001, in comparison with respective control. NS=not significant.
doi:10.1371/journal.pone.0037064.g008
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S5).
Discussion
The present study has identified a novel mechanism that could
potentially play a key role in up-regulating testosterone production
by rat fetal LC during and after the critical masculinization
programming window (MPW) [1,2]. The mechanism we propose
is a progressive age-related reduction in expression of COUP-TFII
in fetal LC, which effectively removes repression by a competitor
with SF-1 for binding to overlapping sites in the promoter region
of steroidogenic enzyme genes. The present results show that this
mechanism is perturbed by exposure to three separate factors in
the rat, some of which may be relevant to the human and other
species. This mechanism could also partly account for the
previously unexplained ‘paracrine’ regulation of fetal LC steroido-
genesis during the MPW in rats and humans [1]. Our proposal
would add another tier of evidence for the COUP-TF family being
active repressors of key elements in the male reproductive system,
ranging from luteinizing hormone expression (LHb; [29]) through
LH receptor expression (LHR; [30,31,32]) to fetal LC function (this
study). Our results also identify, for the first time, a primary
mechanism by which phthalates, such as DBP, inhibit steroido-
genesis by fetal LC in the rat (but not in the mouse). Our studies
show that the COUP-TFII mechanism is present in human fetal
LC, but whether it plays a role analogous to that which we propose
in the rat will depend on further studies.
Our results provide convincing time course and dose-response
evidence that exposure to DBP, DES and to a lesser extent
dexamethasone, prevent the normal time-dependent down-regu-
lation of nuclear COUP-TFII that occurs in fetal LC in the rat and
which is associated temporally with expansion of LC cytoplasmic
volume (which harbors the steroidogenic organelles) and increase
in ITT. The temporal changes fit with the demonstration that
DBP-induced down-regulation of SF-1-dependent LC-specific
genes first emerges at e17.5 [12], consistent with this being the
earliest age at which COUP-TFII expression in LC in control
animals is down-regulated, a change prevented by DBP-treatment.
We show that treatment-induced changes in LC nuclear COUP-
TFII expression are, in all instances, associated with inverse
changes in ITT and with altered expression of SF-1-dependent
LC-specific genes that have shared/overlapping SF-1 and COUP-
TFII response elements in their promoter regions (Table 1). In
contrast, expression of the LC steroidogenic gene (3b-HSD) that
does not have an overlapping SF-1 and COUP-TFII response
element in its promoter, was unaffected by DBP exposure, as was
expression of Amh in Sertoli cells; in the latter case, there are
separate SF-1 and COUP-TFII response elements in the promoter
of Amh (Table 1), but in any case COUP-TFII was never expressed
in Sertoli cells in our studies. Therefore, we show a robust
association between the LC-specific expression of COUP-TFII,
reduced ITT and the down-regulation of steroidogenic genes that
have overlapping SF-1 and COUP-TFII response elements.
Our identification of altered COUP-TFII expression in fetal
rat LC as a mechanism underlying suppression of ITT resulting
from experimental treatments (DBP and/or Dex or DES) is
based on showing a consistent inverse association between the
percentage of fetal LC expressing COUP-TFII in their nuclei
and ITT levels. This association does not in itself prove ‘cause
and effect’. The ideal way of proving this would be to over-
express COUP-TFII in fetal LC and show this reduces
testosterone production. Such studies have been done with
adult-derived bovine steroidogenic cells via transfection and
shown to result in reduced steroidogenesis and expression of StAR
and Cyp17a1 [18,19,20], as found in the present association
studies. Numerous studies have shown that the mechanism
underlying such effects involves competition between COUP-
TFII and SF-1 for binding to an overlapping response element in
the promoter region of genes encoding steroidogenic enzymes
[18,19,20,21,23,30,31,32,33,34,35,36,37,38], as proposed for the
present studies in fetal rat LC. Unfortunately, our studies using
viral transfection of ex vivo cultured rat fetal LC with COUP-TFII
resulted in cell death (unpublished data), and there are also
inherent problems with the culture of fetal LC, which rapidly
lose their steroidogenic function [24]. Therefore, this direct
approach was not an option for us. We therefore decided on two
alternative approaches to provide stronger evidence for causa-
tion, one involving re-induction of COUP-TFII in rat fetal LC
(by DBP treatment) after its age-related loss, and the second
involving parallel studies in the mouse in which DBP had been
shown by others to be incapable of suppressing steroidogenesis
and the expression of SF-1-dependent genes [26,27,39].
For the first approach, we exposed pregnant rats to DBP at
a time in gestation (from e19.5–e20.5) when COUP-TFII had
already switched off in the majority of fetal LC. This ‘late window’
DBP treatment resulted in re-induction of COUP-TFII expression
in most of the fetal LC and an associated reduction in ITT at
e21.5, consistent with our mechanistic proposal. In our mouse
studies we confirmed that DBP exposure had no effect on ITT,
nor was there induction/maintenance of COUP-TFII expression
in fetal LC. However, exposure of pregnant mice to DES, rather
than DBP, did result in profound suppression of ITT and
a corresponding increase in the percentage of fetal LC expressing
COUP-TFII, a change that paralleled that found for DES in the
rat. The degree of suppression of ITT induced by DES was
notably larger than that induced by DBP (in the rat), a difference
probably explained by a parallel reduction in LH drive to the LC
due to reduced LHR expression. This raises the possibility that LH
secretion, which is initiated at ,e18.5 in the rat and increases
progressively thereafter [1], might be involved in switching off the
expression of COUP-TFII in fetal LC and that DBP causes its
steroidogenic effects by suppressing LH. As we were unable to
measure fetal LH in blood, we could not test this possibility
directly, but existing data suggests it is an unlikely explanation for
our findings. First, it would fail to explain why the effects of DBP
on ITT and steroidogenic enzyme expression in rats are first
detectable at e17.5 (this study and [12]), an age prior to the
production of LH in the rat [1]. Second, in vitro studies using rat
fetal testis cultures show that phthalate metabolites inhibit
testosterone production regardless of the absence or presence of
LH in the culture media [40]. Nevertheless, even if DBP did
suppress LH, it would appear that this suppression then results
locally in a failure of COUP-TFII to switch off normally in fetal
LC, which would still represent the causal mechanism within the
LC. Moreover, if DBP exposure should inhibit fetal LH secretion,
it is likely to involve a similar mechanism to that which we propose
for the fetal LC, as COUP-TFII has been shown to competitively
antagonize SF-1-induced LHb expression in the adult pituitary
gland [29].
We considered reverse causation as an alternative explanation
for our findings, namely that because reduced ITT was found in
every instance in which there was abnormal maintenance/
induction of COUP-TFII expression in fetal LC, then the former
could be driving the latter. We consider this unlikely, because in
complete androgen receptor knockout (ARKO) mice the fetal LC
at e18.5 are predominantly immunonegative for COUP-TFII and,
COUP-TFII Function in Fetal Leydig Cells
PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e37064Figure 9. Effect of in utero exposure of mice to vehicle (control), dibutyl phthalate (DBP 500 mg/kg/day) or to diethylstilbestrol
(DES 100 mg/kg on e11.5, e13.5, e15.5 and e17.5) on COUP-TFII immunoexpression in fetal Leydig cells at e18.5. (A–B, E–F) Triple
immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-TFII (green) on testis sections from representative vehicle (control; A, E), DBP-exposed
(B) and DES-exposed (F) animals. Scale bars=50 mm. Asterisks indicate blood vessels. Arrows in F indicate COUP-TFII-positive Leydig cells. (C–D)
Quantification of the percentage of COUP-TFII positive fetal Leydig cells (C) and corresponding intratesticular testosterone levels (D) in control and
DBP-exposed animals. Values are Means 6 SEM for 7 animals per group (minimum of 3 litters per group). (G–H) Quantification of the percentage of
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receptor and are thus not directly androgen-responsive [41].
Our analyses of COUP-TFII expression in fetal LC used
confocal microscopy and identification of LC by cytoplasmic
staining for 3b-HSD. We were able to do this because, unlike the
other SF-1-regulated LC steroidogenic genes, expression of 3b-
HSD was unaffected in any of our treatment groups. Use of high
resolution tiled images of complete fetal testis cross-sections
allowed us to identify fetal LC unequivocally and to specifically
assess the presence or absence of COUP-TFII expression in
individual LC. Since COUP-TFII is abundantly expressed in
other cell types in the fetal testis, especially in non-Leydig
interstitial cells, whole testis measurements such as the analysis
of total testicular COUP-TFII mRNA expression would not be
meaningful, and, indeed, we found no effect of DBP-exposure on
overall COUP-TFII mRNA expression in the fetal rat testis. We
saw no evidence for altered COUP-TFII expression in the non-
Leydig interstitial cells in the fetal testis, and these cells did not
affect our analyses because these were focused only on identifiable
fetal LC (ie cells expressing 3b-HSD in their cytoplasm). We chose
an antibody dilution for detection of COUP-TFII immunoexpres-
sion that discriminated between immunonegative LC in controls
and immunopositive LC in DBP-exposed animals. In reality, we
think it likely that this distinction represents profound down-
regulation, rather than complete absence, of COUP-TFII
immunoexpression in the nuclei of late gestation fetal LC in
controls, based on titration studies with the COUP-TFII antibody
(Fig. S6).
Based on the age-related change in COUP-TFII immunoex-
pression in fetal human LC in the present studies, the mechanism
which we propose for COUP-TFII in the rat may apply to the
human, but more detailed studies are needed to support this
COUP-TFII positive fetal Leydig cells (G) and corresponding intratesticular testosterone levels (H) in control and DES-exposed animals. Values are
Means 6 SEM for 6–9 animals per group (minimum of 3 litters per group). ***p,0.001, in comparison with respective control. NS=not significant.
doi:10.1371/journal.pone.0037064.g009
Figure 10. COUP-TFII expression in fetal Leydig cells in human fetal testis samples from late 1
st trimester (A), early 2
nd trimester (B)
and late 2
nd trimester (C). Triple immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-TFII (green) on human fetal testis sections.
SC=seminiferous cords. Scale bars=50 mm. (D) Quantification of the percentage of COUP-TFII positive fetal Leydig cells in samples shown in panels
A–C. Values are Means 6 SEM for 3–11 samples per treatment group. *p,0.05, **p,0.01, in comparison with respective control; other comparison is
indicated by capped line.
doi:10.1371/journal.pone.0037064.g010
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shown to affect this mechanism in the rat will apply to the human,
as our preliminary data is that in the human, as in mice, DBP
neither affects steroidogenesis [42] nor COUP-TFII expression
(our unpublished data), at least in a xenograft model system.
Nevertheless, as we show that three separate factors can maintain/
increase nuclear expression of COUP-TFII in fetal rat LC with
associated decreases in fetal ITT, it suggests that the COUP-TFII
mechanism is potentially vulnerable to a wider range of factors.
In conclusion, our results all point strongly towards COUP-
TFII expression being a key (negative) regulator of steroidogenesis
within fetal LC during and after the critical period for
masculinization in the rat, and potentially in the human. Thus,
lifting of steroidogenic repression by COUP-TFII, rather than
direct stimulation of steroidogenesis by paracrine factors, could be
the primary LH-independent mechanism responsible for in-
creasing testosterone production to induce masculinization.
Perturbation of this novel pathway is clearly linked via our DBP
studies in the rat to downstream TDS disorders. We show that this
pathway can be impacted by factors other than DBP, for example
via the stress hormone axis (glucocorticoids) and by estrogens. We
consider it likely that other factors (eg other environmental
chemicals) also target this pathway. The present findings suggest
new pathways by which lifestyle factors in combination with
environmental chemicals could exert adverse effects and lead to
TDS disorders.
Methods
Animals and treatments
Wistar rats and C57BL/6J mice were maintained according to
UK Home Office guidelines (which also involves an ethical
approval step) and were fed a soy-free breeding diet (RM3(E) soya
free; SDS, Dundee, Scotland). Housing conditions were carefully
controlled (lights on at 0700, off at 1900 h, temperature 19–21 C,
GOLD shavings and LITASPEN standard bedding (SPPS,
Argenteuil, France)). Time-mated female rats were subjected to
the daily treatments described below. Depending on the age of
termination, treatments were administered from embryonic day (e)
13.5–e14.5 (termination e15.5), e13.5–e16.5 (termination e17.5),
e13.5–e18.5 (termination e19.5), e13.5–e20.5 (termination e21.5)
or e13.5–e21.5 (termination in adulthood) between 0900 and
1030 h. In a different set of experiments treatments were
administered from e19.5–e20.5 (termination e21.5; late treatment
window). The doses of dibutyl phthalate (DBP), dexamethasone
(Dex) and diethylstilbestrol (DES) were based on previous studies
[3,9,25,43]. The DBP was 99% pure according to the supplier.
Rat treatment groups were as follows:
1) DBP (Sigma-Aldrich Co. Ltd., Dorset, UK) at a dose of
either 20, 100 or 500 mg/kg administered by oral gavage in
1 ml/kg corn oil, plus daily subcutaneous injection of 1 ml/
kg saline (vehicle control for Dex).
2) Dex (Sigma-Aldrich) at a dose of 100 mg/kg/day by
subcutaneous injection in 1 ml/kg saline plus 1 ml/kg corn
oil by oral gavage (vehicle control for DBP).
3) A combination of DBP (500 mg/kg by oral gavage) plus Dex
(100 mg/kg/day subcutaneously).
4) DES (Sigma-Aldrich) at a dose of 100 mg/kg in 1 ml/kg
corn oil by subcutaneous injection on e13.5, e15.5, e17.5,
e19.5 and e20.5.
5) Control (1 ml/kg corn oil by gavage and 1 ml/kg saline by
subcutaneous injection).
Additionally, pregnant female mice were treated with DBP
(500 mg/kg by oral gavage from e11.5 to e17.5) or DES (100 mg/
kg by subcutaneous injection on e13.5, e15.5 and e17.5) and were
terminated on e18.5. Androgen receptor knockout (ARKO) mice
were generated as described previously [44], and were terminated
at e18.5.
Tissue recovery, processing and adult rat phenotyping
To acquire fetal samples, rat dams were killed by inhalation of
CO2 followed by cervical dislocation at e15.5, e17.5, e19.5, e21.5
or adulthood and mouse dams at e18.5. Fetuses were removed,
decapitated and placed in ice cold phosphate buffered solution
(PBS; Sigma-Aldrich). Testes were microdissected, and fixed in
Bouin’s fixative for 1 hour at room temperature or snap frozen
and stored at 270uC for gene expression analysis or determination
of intratesticular testosterone (ITT) by homogenizing the testis and
measuring its total testosterone content using a radioimmunoassay
as described previously [9]. The limit of detection of the
testosterone assay was 40 pg and the intra- and inter-assay CVs
were ,9% and ,14%, respectively. Bouin’s-fixed tissues were
processed and embedded in paraffin wax, and 5-mm sections were
used for subsequent experiments. Adult rats exposed to 500 mg/
kg DBP or vehicle control were subjected to a thorough inspection
to determine the normality of the penis and testicular descent as
described previously [3]. In addition the testes of these adult rats
were dissected and weighed.
Human fetal testis samples
First- and second-trimester testes were obtained after medical
termination of pregnancy for social reasons as described previously
[45]. Written maternal consent was obtained, and the study was
approved by the Lothian Research Ethics Committee. Gestation
was determined by ultrasound scan and subsequent direct
measurement of foot length. The sex of first-trimester testes was
confirmed by PCR for the male-specific gene SRY. Testes were
removed and fixed in Bouin’s fixative for 2 hours before
processing into paraffin using standard methods. A total of 24
fetal specimens were used in this study: 3 late 1
st trimester samples
(,12 weeks), 10 early 2
nd trimester samples (12–17 weeks) and 11
late 2
nd trimester samples (18–20 weeks).
Determination of Leydig (3b-hydroxysteroid
dehydrogenase-immunopositive) cell number, nuclear
volume and cytoplasmic volume per testis
Testicular sections from 4–8 animals per age/treatment group
were immunostained for 3b-hydroxysteroid dehydrogenase (3b-
HSD) as described previously [46] and counterstained with
hematoxylin. The volume of Leydig (3b-HSD-positive) cells per
testis was determined using stereological methods similar to those
described previously [47]. Briefly, three (non-serial) sections per
animal were analyzed using a Zeiss Axio-Imager microscope (Carl
Zeiss Ltd., Welwyn Garden City, UK) fitted with a Hitachi HV-
C20 camera (Hitachi Denshi Europe, Leeds, UK) and a Prior
automatic stage (Prior Scientific Instruments Ltd., Cambridge,
UK). Image-Pro 6.2 with Stereologer plug-in software (Mag-
Worldwide, Wokingham, UK) was used to select random fields
and to place a counting grid over the tissue. The total number of
fields counted per animal (,65–95 fields) was dependent on
obtaining a percentage SE value of ,5%. Points falling over 3b-
HSD-positive cytoplasm, or over the nuclei of cells with 3b-HSD-
positive cytoplasm, were scored separately, and both were
independently expressed as relative volumes per testis. These data
were converted to absolute volume per testis by multiplying by
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converted to cell number per testis after determination of mean
LC nuclear diameter and volume (,100 nuclei per animal) using
the Stereologer software nucleator function. Average LC cyto-
plasmic volume was calculated by dividing total LC cytoplasmic
volume per testis by the number of LC.
Immunofluorescence for Smooth Muscle Actin, 3b-HSD
and COUP-TFII
In order to delineate the seminiferous cord compartment from
the interstitial compartment and to distinguish COUP-TFII
positive fetal LC from other COUP-TFII positive interstitial and
peritubular myoid cells, specific antibodies were used for the co-
immunolocalization of a-smooth muscle actin (a-SMA; clone 1A4,
Sigma-Aldrich), 3b-HSD (for rat and mouse: clone P-18, Santa
Cruz Biotechnology, Inc., CA, USA; for human: the antibody was
a kind gift of professor Ian Mason) and COUP-TFII (clone
H7147, R&D Systems, MN, USA). All washes between incubation
steps were in TBS (365 min) and all incubations were carried out
in a humidity box (Fisher Scientific, UK). Sections were dewaxed
and rehydrated, followed by a peroxidase block in 3% (v/v) H2O2
in methanol for 30 min. Next, the sections were blocked in normal
rabbit serum (NRS; Biosera, Ringmer, UK) diluted 1:5 in TBS
containing 5% (w/v) BSA (NRS/TBS/BSA), followed by in-
cubation with anti-SMA antibody diluted 1:10,000 in NRS/TBS/
BSA for 1 hour at room temperature (RT). Sections were then
incubated with peroxidase-conjugated rabbit anti-mouse second-
ary antibody (RAMP; DAKO Corp., Cambridge, UK), diluted
1:200 in NRS/TBS/BSA for 30 minutes at RT, followed by
incubation with Tyr-Cy5 (Perkin Elmer-TSA-Plus Cyanine5
System; Perkin Elmer Life Sciences, Boston, MA, USA) according
to the manufacturer’s instructions. Sections were then subjected to
antigen retrieval by boiling in a pressure cooker in 0.01 mol/l
citrate buffer (pH 6.0) for 5 min and left to cool for 20 minutes,
followed by another block in NRS/TBS/BSA and overnight
incubation at 4uC with anti-3b-HSD antibody diluted 1:8,000 in
NRS/TBS/BSA. Slides were then incubated with peroxidise-
conjugated rabbit anti-goat secondary antibody (Sigma-Aldrich)
diluted 1:200 in NRS/TBS/BSA for 30 minutes at RT, followed
by incubation with Tyr-Cy3 (Perkin Elmer-TSA-Plus Cyanine3
System; Perkin Elmer Life Sciences) according to the manufac-
turer’s instructions. Sections were again blocked against peroxi-
dase in 3% (v/v) H2O2 in TBS plus 0.01% (v/v) Tween-20
(Sigma-Aldrich) for 20 min followed by blocking in NRS/TBS/
BSA and overnight incubation at 4uC with anti-COUP-TFII
antibody diluted 1:1,000 in NRS/TBS/BSA. Finally, on the third
day, sections were incubated with RAMP diluted 1:200 in NRS/
TBS/BSA for 30 minutes at RT, and followed by incubation with
Tyr-fl (Perkin Elmer-TSA-Plus Fluorescein System; Perkin Elmer
Life Sciences) according to the manufacturer’s instructions.
Fluorescent images were captured using a Zeiss LSM 710 Axio
Observer Z1 confocal laser microscope (Carl Zeiss Ltd.). All
images were compiled using Photoshop 9.0 (Adobe Systems Inc.).
Quantification of COUP-TFII positive fetal LC
Preliminary studies showed that, at e21.5, when DBP (500 mg/
kg/day) exposure reduces ITT, this was associated with a high
percentage of fetal LC expressing COUP-TFII in their nuclei,
whereas in controls most LC nuclei were negative for COUP-TFII
(Fig. 4,5). To validate this observation, COUP-TFII immunoex-
pression in LC nuclei in control and DBP-exposed animals was
evaluated using serial dilutions of COUP-TFII antibody. This
showed unequivocally that the level of COUP-TFII immunoex-
pression was considerably higher in DBP-exposed animals than in
controls (Fig. S6). Based on these studies, an antibody dilution of
1:1000 was chosen for the remaining studies, as this discriminated
LC nuclear COUP-TFII immunoexpression clearly between
control and DBP-exposed animals at a dose of DBP that was
associated with induction of TDS disorders (Fig. 1). High
resolution tiled confocal scanning laser microscopy images of
complete testis cross sections co-stained for SMA, 3b-HSD and
COUP-TFII were generated and used for determining the
proportion of fetal LC which stained positively for COUP-TFII.
At least 5 different testes per age and treatment group were used
for counting. Briefly, exported images were opened using Image-
Pro 6.2 software (MagWorldwide) and all LC in the image were
counted (range in numbers=25–1693; median 472 per testis
cross-section) and scored negative or positive for nuclear COUP-
TFII staining.
Gene expression analysis at e21.5
For quantitative analysis of gene expression by RT-PCR, total
RNA was extracted from e21.5 testis samples from the different
treatment groups (controls, Dex-100 mg/kg, DBP-500 mg/kg,
Dex-100 mg/kg + DBP-500 mg/kg, DES-100 mg/kg) using the
RNeasy Micro Kit with on-column DNase digestion (Qiagen,
UK). Random hexamer primed cDNA was prepared using the
Applied Biosystems Taqman
TM RT kit (Applied Biosystems, CA).
Quantitative real time PCR (qRT-PCR) was performed on the
ABI Prism Sequence Detection System (Applied Biosystems).
Expression of rat StAR, Cyp11a1, Cyp17a1, 3b-HSD, Amh, LHR and
COUP-TFII mRNA was determined using the Roche Universal
Probe Library (StAR forward primer: 59-TCACGTGGCTGCT-
CAGTATT-39, reverse primer: 59-GGGTCTGTGATAA-
GACTTGGTTG-39, probe number 83 Cat no. 04689062001;
Cyp11a1 forward primer: 59-TATTCCGCTTTGCCTTTGAG-
39, reverse primer 59-CACGATCTCCTCCAACATCC-39, probe
number 9 Cat no. 04685075001; Cyp17a1 forward primer: 59-
CATCCCCCACAAGGCTAAC-39, reverse primer: 59-
TGTGTCCTTGGGGACAGTAAA-39, probe number 67 Cat
no. 04688660001; Amh forward primer: 59-CTGGA-
CACCGTGCCTTTC-39, reverse primer: 59-CACTGTGTGG-
CAGGTCCTC-39, probe number 26 Cat no. 04687574001; 3b-
HSD forward primer: 59-GACCAGAAACCAAGGAGGAA-39,
reverse primer: 59-CTGGCACGCTCTCCTCAG-39, probe
number 105 Cat no. 04692241001; LHR forward primer: 59-
CTGGAGAAGATGCACAGTGG-39, reverse primer 59-
CTGCAATTTGGTGGAAGAAATA-39, probe number 107
Cat no. 04692268001; COUP-TFII forward primer: 59-CGGAG-
GAACCTGAGCTACAC-39, reverse primer 59-CCACTTT-
GAGGCACTTTTTGA-39, probe number 123 Cat
no. 04693574001; Roche Applied Sciences, Burgess Hill, UK).
The expression level of each gene was corrected using a ribosomal
18S internal control (Applied Biosystems Cat no. 4308329). All
samples were performed in triplicate and a relative comparison
was made to adult testis control cDNA. For each treatment group,
at least fifteen e21.5 rat fetuses from 5 litters were analyzed.
Immunohistochemistry for Cyp11a1, 3b-HSD and Amh
Specific protein expression of Cyp11a1, 3b-HSD and Amh
were detected by immunohistochemistry on e21.5 testis sections
isolated from control and DBP-exposed animals, using standard
methods that have been detailed previously [12,48]. The primary
antibodies and their dilutions used in the present studies were as
follows: rabbit anti-Cyp11a1 (1:200; Chemicon International Inc.,
Temecula, CA, USA), goat anti-3b-HSD (1:800; Santa Cruz
Biotechnology, Santa Cruz, CA, USA), goat anti-Amh (1:30;
Santa Cruz Biotechnology, Santa Cruz, CA, USA).
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Data were analysed using GraphPad Prism version 5 (Graph
Pad Software Inc., San Diego, CA) and one-way Analysis of
Variance followed by the Bonferroni post-test, or student t-test
when control and treated groups at a particular age were
compared. The Fisher’s exact test was used for comparing the
incidence of cryptorchidism and hypospadias in vehicle- and DBP-
exposed treatment groups. Data for fetal ITT and mRNA levels
were log transformed prior to analysis to normalize variances.
Supporting Information
Figure S1 Effect of in utero exposure of rats to vehicle
(control), or dibutyl phthalate (DBP 500 mg/kg/day) on
the mRNA expression of COUP-TFII in the fetal testis at
e21.5. Values are Means 6 SEM for 11–14 animals per group
(minimum of 3 litters per group).
(TIF)
Figure S2 COUP-TFII immunoexpression in e21.5 con-
trol testis (A) and corresponding image in (B) showing
DAPI nuclear counterstain. Arrows indicate examples of
nuclear COUP-TFII/DAPI staining which has a ‘‘cytoplasmic’’
appearance, but in fact is all within the nucleus as indicated by
DAPI staining. Scale bar=20 mm.
(TIF)
Figure S3 Effect of in utero exposure of rats to vehicle
(control), Dexamethasone (Dex 100 mg/kg/day), dibutyl
phthalate (DBP 500 mg/kg/day) or a combination of
DBP-500 + Dex on steroidogenic enzyme and anti-
Mu ¨llerian hormone gene expression in testes at e21.5.
(A) Cyp11a1, (B) StAR, (C) Cyp17a1, (D) 3b-HSD, and (E) Amh. Note
the lack of effect of treatments on expression of 3b-HSD and Amh.
Values are Means 6 SEM for 19–22 animals per group (minimum
of 5 litters per group). *p,0.05, **p,0.01, ***p,0.001, in
comparison with respective control.
(TIF)
Figure S4 Effect of in utero exposure of rats to (A)
vehicle (control), dexamethasone (Dex 100 mg/kg/day),
dibutyl phthalate (DBP 500 mg/kg/day) or a combina-
tion of DBP-500 + Dex or (B) diethylstilbestrol (DES
100 mg/kg) on luteinizing hormone receptor (LHR) gene
expression in testes at e21.5. Values are Means 6 SEM for
11–24 animals per group (minimum of 3 litters per group).
***p,0.001, in comparison with respective control.
(TIF)
Figure S5 COUP-TFII immunoexpression in fetal LC in
control and complete androgen receptor knockout
(ARKO) mice at e18.5. Representative images of control and
ARKO mice (n=4) demonstrating that COUP-TFII is only rarely
expressed (arrows) in ARKO fetal LC as in wild-type controls.
Scale bar=20 mm.
(TIF)
Figure S6 Serial dilution of COUP-TFII antibody. Triple
immunofluorescence for SMA (blue), 3b-HSD (red) and COUP-
TFII (green) on fetal testis sections from vehicle (control) and DBP-
exposed (500 mg/kg/day) e21.5 animals. Note that in control
sections most Leydig cells are COUP-TFII-immunopositive at low
antibody dilutions (1:250–1:500) whereas only a minority is at
lower antibody dilutions. In contrast, in sections from DBP-
exposed animals, most Leydig cells are COUP-TFII-immunopo-
sitive at all antibody dilutions. SC=seminiferous cords. A wider
range of antibody dilutions were run than is shown. Scale
bar=20 mm.
(TIF)
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